Ibrutinib is used to treat mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, and small lymphocytic lymphoma.
Ibrutinib is also used to treat chronic graft-versus-host disease.
Ibrutinib may also be used for purposes not listed in this medication guide.
